Company intelligence / Profile preview

Symborg

Murcia, Spain

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Symborg develops and commercializes biological products, based on microorganisms, that support agricultural productivity and sustainability across more than 40 countries. While their work is at the front of biotechnology applied to agriculture, they do not have programs for human health and clinical trials.

Modalities: Microbial therapy
Industry: Agriculture & AgTech

Partnerships

International Mycorrhiza Society (IMS)International Biocontrol Manufacturers Association (IBMA)Biological Products Industry Alliance (BPIA)

Beyond the preview

Go deeper on Symborg.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symborg.

Explore the full profile